Aug 31, 2018 - One sector has been tearing up the S&P 500 this quarter, rocketing to new highs, and it's not tech. Health care has been the surprise winner as the third quarter enters the home stretch.
Sep 05, 2018 - Allergan PLC (NYSE:AGN) 2018 Wells Fargo Healthcare Conference Call September 05, 2018 09:05 AM ET Executives Brent Saunders - Chief Executive Officer Analysts David Maris - Wells Fargo Securities Pre
Sep 09, 2018 - Top Insider Buys Highlight for the Week of Sept. 7, Stocks: AXP,SLB,AGN,KDP, release date:Sep 07, 2018
Sep 12, 2018 - But for PMD, Big pharma drug makers and biotech continued to top the healthcare sector by yield and broker targets. WallStars are distinguished by positive broker target price upsides.The Healthcare s
Sep 18, 2018 - Alnylam had an eventful week.Karyopharm reports positive Phase 2 data.Teva’s migraine drug is approved.
Sep 27, 2018 - Urovant is a clinical-stage biopharmaceutical company developing treatments for urologic conditions.The company is selling 10 million common shares at a price between $14.00 and $16.00 per common shar
Sep 27, 2018 - FDA accepts Allergan's (AGN) sNDA for label expansion of its schizophrenia drug, Vraylar (cariprazine) to include treatment of bipolar depression.
Sep 28, 2018 - FDA grants approval to Lilly's (LLY) Emgality for migraine and Pfizer's (PFE) Vizimpro for an advanced lung cancer indication. Novartis (NVS) to cut more than 2,000 jobs in Switzerland and U.K
Oct 03, 2018 - Paratek (PRTK) gets FDA approval for Nuzyra for the treatment of serious community-acquired bacterial infections and Seysara for the treatment of acne.
Oct 09, 2018 - VistaGen is a clinical-stage biopharmaceutical company developing treatments to fight depression and other central nervous system illnesses.With a large target market size and candidates at Phase 2 of